x | QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
New York | 13-5593032 | |||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
111 River Street, Hoboken, New Jersey | 07030 | |||||||
(Address of principal executive offices) | Zip Code |
(201) 748-6000 | ||||||||
Registrant’s telephone number, including area code |
Not Applicable | ||||||||
Former name, former address and former fiscal year, if changed since last report |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
Class A Common Stock, par value $1.00 per share | WLY | New York Stock Exchange | ||||||||||||
Class B Common Stock, par value $1.00 per share | WLYB | New York Stock Exchange |
Large accelerated filer x | Accelerated filer o | ||||
Non-accelerated filer o | Smaller reporting company o | ||||
Emerging growth company o |
PART I - FINANCIAL INFORMATION | ||||||||
Item 5. | ||||||||
October 31, 2023 | April 30, 2023 | ||||||||||
Assets: | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 83,218 | $ | 106,714 | |||||||
Accounts receivable, net of allowance for credit losses of $15.1 million and $18.7 million, respectively | 147,253 | 310,121 | |||||||||
Inventories, net | 30,131 | 30,733 | |||||||||
Prepaid expenses and other current assets | 58,583 | 93,711 | |||||||||
Current assets held-for-sale | 106,384 | — | |||||||||
Total current assets | 425,569 | 541,279 | |||||||||
Technology, property and equipment, net | 222,504 | 247,149 | |||||||||
Intangible assets, net | 630,562 | 854,794 | |||||||||
Goodwill | 1,081,517 | 1,204,050 | |||||||||
Operating lease right-of-use assets | 79,009 | 91,197 | |||||||||
Other non-current assets | 136,782 | 170,341 | |||||||||
Non-current assets held-for-sale | 203,100 | — | |||||||||
Total assets | $ | 2,779,043 | $ | 3,108,810 | |||||||
Liabilities and shareholders' equity: | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | 48,512 | $ | 84,325 | |||||||
Accrued royalties | 105,552 | 113,423 | |||||||||
Short-term portion of long-term debt | 5,000 | 5,000 | |||||||||
Contract liabilities | 235,839 | 504,695 | |||||||||
Accrued employment costs | 82,935 | 80,458 | |||||||||
Short-term portion of operating lease liabilities | 17,804 | 19,673 | |||||||||
Other accrued liabilities | 72,331 | 87,979 | |||||||||
Current liabilities held-for-sale | 42,277 | — | |||||||||
Total current liabilities | 610,250 | 895,553 | |||||||||
Long-term debt | 937,624 | 743,292 | |||||||||
Accrued pension liability | 76,005 | 86,304 | |||||||||
Deferred income tax liabilities | 94,278 | 144,042 | |||||||||
Operating lease liabilities | 101,816 | 115,540 | |||||||||
Other long-term liabilities | 78,169 | 79,052 | |||||||||
Long-term liabilities held-for-sale | 13,625 | — | |||||||||
Total liabilities | 1,911,767 | 2,063,783 | |||||||||
Commitments and contingencies (Note 18) | |||||||||||
Shareholders’ equity | |||||||||||
Preferred stock, $1 par value per share: Authorized shares – 2 million, Issued shares - 0 | — | — | |||||||||
Class A common stock, $1 par value per share: Authorized shares - 180 million, Issued shares - 70,234 and 70,231 as of October 31, 2023 and April 30, 2023, respectively | 70,234 | 70,231 | |||||||||
Class B common stock, $1 par value per share: Authorized shares - 72 million, Issued shares - 12,948 and 12,951 as of October 31, 2023 and April 30, 2023, respectively | 12,948 | 12,951 | |||||||||
Additional paid-in-capital | 471,169 | 469,802 | |||||||||
Retained earnings | 1,710,358 | 1,860,872 | |||||||||
Accumulated other comprehensive loss, net of tax | (541,970) | (528,902) | |||||||||
Less treasury shares at cost (Class A – 24,393 and 23,983 as of October 31, 2023 and April 30, 2023, respectively; Class B – 3,926 and 3,925 as of October 31, 2023 and April 30, 2023, respectively) | (855,463) | (839,927) | |||||||||
Total shareholders’ equity | 867,276 | 1,045,027 | |||||||||
Total liabilities and shareholders' equity | $ | 2,779,043 | $ | 3,108,810 |
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Revenue, net | $ | 492,808 | $ | 514,836 | $ | 943,821 | $ | 1,002,405 | |||||||||||||||
Costs and expenses: | |||||||||||||||||||||||
Cost of sales | 155,614 | 170,302 | 312,715 | 344,333 | |||||||||||||||||||
Operating and administrative expenses | 252,282 | 253,029 | 508,083 | 535,780 | |||||||||||||||||||
Impairment of goodwill | — | — | 26,695 | — | |||||||||||||||||||
Restructuring and related charges | 25,102 | 13,956 | 37,225 | 36,397 | |||||||||||||||||||
Amortization of intangible assets | 13,565 | 20,110 | 29,213 | 45,421 | |||||||||||||||||||
Total costs and expenses | 446,563 | 457,397 | 913,931 | 961,931 | |||||||||||||||||||
Operating income | 46,245 | 57,439 | 29,890 | 40,474 | |||||||||||||||||||
Interest expense | (12,937) | (9,332) | (24,271) | (15,664) | |||||||||||||||||||
Foreign exchange transaction (losses) gains | (2,357) | 478 | (3,977) | (138) | |||||||||||||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | (51,414) | — | (127,343) | — | |||||||||||||||||||
Other (expense) income, net | (1,567) | (255) | (3,052) | 271 | |||||||||||||||||||
(Loss) income before taxes | (22,030) | 48,330 | (128,753) | 24,943 | |||||||||||||||||||
(Benefit) provision for income taxes | (2,585) | 10,137 | (17,044) | 4,585 | |||||||||||||||||||
Net (loss) income | $ | (19,445) | $ | 38,193 | $ | (111,709) | $ | 20,358 | |||||||||||||||
(Loss) earnings per share | |||||||||||||||||||||||
Basic | $ | (0.35) | $ | 0.69 | $ | (2.02) | $ | 0.37 | |||||||||||||||
Diluted | $ | (0.35) | $ | 0.68 | $ | (2.02) | $ | 0.36 | |||||||||||||||
Weighted average number of common shares outstanding | |||||||||||||||||||||||
Basic | 55,102 | 55,622 | 55,186 | 55,679 | |||||||||||||||||||
Diluted | 55,102 | 56,195 | 55,186 | 56,326 | |||||||||||||||||||
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Net (loss) income | $ | (19,445) | $ | 38,193 | $ | (111,709) | $ | 20,358 | |||||||||||||||
Other comprehensive (loss) income: | |||||||||||||||||||||||
Foreign currency translation adjustment | (33,865) | (36,148) | (22,691) | (55,928) | |||||||||||||||||||
Unamortized retirement credits, net of tax (expense) of $(2,796), $(2,257), $(2,412), and $(3,737), respectively | 9,994 | 8,146 | 8,157 | 13,227 | |||||||||||||||||||
Unrealized (loss) gains on interest rate swaps, net of tax benefit (expense) of $331, $(1,809), $(532), and $(1,748) respectively | (1,054) | 5,305 | 1,466 | 4,861 | |||||||||||||||||||
Total other comprehensive loss | (24,925) | (22,697) | (13,068) | (37,840) | |||||||||||||||||||
Comprehensive (loss) income | $ | (44,370) | $ | 15,496 | $ | (124,777) | $ | (17,482) |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Operating activities | |||||||||||
Net (loss) income | $ | (111,709) | $ | 20,358 | |||||||
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||||||||||
Impairment of goodwill | 26,695 | — | |||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | 127,343 | — | |||||||||
Amortization of intangible assets | 29,213 | 45,421 | |||||||||
Amortization of product development assets | 12,937 | 16,452 | |||||||||
Depreciation and amortization of technology, property and equipment | 41,752 | 48,827 | |||||||||
Restructuring and related charges | 37,225 | 36,397 | |||||||||
Stock-based compensation expense | 12,801 | 13,998 | |||||||||
Employee retirement plan expense | 17,590 | 14,622 | |||||||||
Foreign exchange transaction losses | 3,977 | 138 | |||||||||
Gain on sale of certain assets | — | (40) | |||||||||
Other noncash credits | (39,895) | (8,514) | |||||||||
Net change in operating assets and liabilities | (241,415) | (263,855) | |||||||||
Net cash used in operating activities | (83,486) | (76,196) | |||||||||
Investing activities | |||||||||||
Product development spending | (8,168) | (11,445) | |||||||||
Additions to technology, property and equipment | (40,321) | (38,530) | |||||||||
Businesses acquired in purchase transactions, net of cash acquired | (1,500) | (96) | |||||||||
Proceeds related to the sale of a business | 1,025 | 40 | |||||||||
Acquisitions of publication rights and other | (2,953) | 1,738 | |||||||||
Net cash used in investing activities | (51,917) | (48,293) | |||||||||
Financing activities | |||||||||||
Repayments of long-term debt | (381,640) | (208,925) | |||||||||
Borrowings of long-term debt | 579,871 | 437,311 | |||||||||
Purchases of treasury shares | (22,500) | (17,500) | |||||||||
Change in book overdrafts | (2,733) | (15,771) | |||||||||
Cash dividends | (38,691) | (38,749) | |||||||||
Impact of tax withholding on stock-based compensation and other | (4,605) | (4,763) | |||||||||
Net cash provided by financing activities | 129,702 | 151,603 | |||||||||
Effects of exchange rate changes on cash, cash equivalents, and restricted cash | (1,943) | (8,784) | |||||||||
Cash reconciliation: | |||||||||||
Cash and cash equivalents | 106,714 | 100,397 | |||||||||
Restricted cash included in Prepaid expenses and other current assets | 548 | 330 | |||||||||
Balance at beginning of period | 107,262 | 100,727 | |||||||||
(Decrease)/increase for the period | (7,644) | 18,330 | |||||||||
Cash and cash equivalents | 99,515 | 118,423 | |||||||||
Restricted cash included in Prepaid expenses and other current assets | 103 | 634 | |||||||||
Balance at end of period (1) | $ | 99,618 | $ | 119,057 | |||||||
Cash paid during the period for: | |||||||||||
Interest | $ | 22,933 | $ | 14,077 | |||||||
Income taxes, net of refunds | $ | 26,423 | $ | 25,349 |
(1) | The balance as of October 31, 2023 includes held-for-sale cash, cash equivalents and restricted cash. See Note 3, "Acquisitions and Divestitures" for further details. |
Class A common stock | Class B common stock | Additional paid-in capital | Retained earnings | Accumulated other comprehensive loss, net of tax | Treasury stock | Total shareholders' equity | |||||||||||||||||||||||||||||||||||
Balance at July 31, 2023 | $ | 70,231 | $ | 12,951 | $ | 465,278 | $ | 1,749,169 | $ | (517,045) | $ | (843,378) | $ | 937,206 | |||||||||||||||||||||||||||
Restricted shares issued under stock-based compensation plans | — | — | (620) | (1) | — | 690 | 69 | ||||||||||||||||||||||||||||||||||
Impact of tax withholding on stock-based compensation and other | — | — | — | — | — | (275) | (275) | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | 6,511 | — | — | — | 6,511 | ||||||||||||||||||||||||||||||||||
Purchases of treasury shares | — | — | — | — | — | (12,500) | (12,500) | ||||||||||||||||||||||||||||||||||
Class A common stock dividends ($0.3500 per share) | — | — | — | (16,207) | — | — | (16,207) | ||||||||||||||||||||||||||||||||||
Class B common stock dividends ($0.3500 per share) | — | — | — | (3,158) | — | — | (3,158) | ||||||||||||||||||||||||||||||||||
Common stock class conversions | 3 | (3) | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Comprehensive loss, net of tax | — | — | — | (19,445) | (24,925) | — | (44,370) | ||||||||||||||||||||||||||||||||||
Balance at October 31, 2023 | $ | 70,234 | $ | 12,948 | $ | 471,169 | $ | 1,710,358 | $ | (541,970) | $ | (855,463) | $ | 867,276 |
Class A common stock | Class B common stock | Additional paid-in capital | Retained earnings | Accumulated other comprehensive loss, net of tax | Treasury stock | Total shareholders' equity | |||||||||||||||||||||||||||||||||||
Balance at July 31, 2022 | $ | 70,226 | $ | 12,956 | $ | 458,578 | $ | 1,883,857 | $ | (523,289) | $ | (820,002) | $ | 1,082,326 | |||||||||||||||||||||||||||
Restricted shares issued under stock-based compensation plans | — | — | (225) | 1 | — | 277 | 53 | ||||||||||||||||||||||||||||||||||
Impact of tax withholding on stock-based compensation and other | — | — | — | — | — | (41) | (41) | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | 6,863 | — | — | — | 6,863 | ||||||||||||||||||||||||||||||||||
Purchases of treasury shares | — | — | — | — | — | (7,500) | (7,500) | ||||||||||||||||||||||||||||||||||
Class A common stock dividends ($0.3475 per share) | — | — | — | (16,252) | — | — | (16,252) | ||||||||||||||||||||||||||||||||||
Class B common stock dividends ($0.3475 per share) | — | — | — | (3,138) | — | — | (3,138) | ||||||||||||||||||||||||||||||||||
Common stock class conversions | 2 | (2) | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Comprehensive loss, net of tax | — | — | — | 38,193 | (22,697) | — | 15,496 | ||||||||||||||||||||||||||||||||||
Balance at October 31, 2022 | $ | 70,228 | $ | 12,954 | $ | 465,216 | $ | 1,902,661 | $ | (545,986) | $ | (827,266) | $ | 1,077,807 |
Class A common stock | Class B common stock | Additional paid-in capital | Retained earnings | Accumulated other comprehensive loss, net of tax | Treasury stock | Total shareholders' equity | |||||||||||||||||||||||||||||||||||
Balance at April 30, 2023 | $ | 70,231 | $ | 12,951 | $ | 469,802 | $ | 1,860,872 | $ | (528,902) | $ | (839,927) | $ | 1,045,027 | |||||||||||||||||||||||||||
Restricted shares issued under stock-based compensation plans | — | — | (11,425) | — | — | 11,569 | 144 | ||||||||||||||||||||||||||||||||||
Impact of tax withholding on stock-based compensation and other | — | — | — | — | — | (4,605) | (4,605) | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | 12,792 | — | — | — | 12,792 | ||||||||||||||||||||||||||||||||||
Purchases of treasury shares | — | — | — | — | — | (22,500) | (22,500) | ||||||||||||||||||||||||||||||||||
Class A common stock dividends ($0.3500 per share) | — | — | — | (32,488) | — | — | (32,488) | ||||||||||||||||||||||||||||||||||
Class B common stock dividends ($0.3500 per share) | — | — | — | (6,317) | — | — | (6,317) | ||||||||||||||||||||||||||||||||||
Common stock class conversions | 3 | (3) | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Comprehensive loss, net of tax | — | — | — | (111,709) | (13,068) | — | (124,777) | ||||||||||||||||||||||||||||||||||
Balance at October 31, 2023 | $ | 70,234 | $ | 12,948 | $ | 471,169 | $ | 1,710,358 | $ | (541,970) | $ | (855,463) | $ | 867,276 |
Class A common stock | Class B common stock | Additional paid-in capital | Retained earnings | Accumulated other comprehensive loss, net of tax | Treasury stock | Total shareholders' equity | |||||||||||||||||||||||||||||||||||
Balance at April 30, 2022 | $ | 70,226 | $ | 12,956 | $ | 459,297 | $ | 1,921,160 | $ | (508,146) | $ | (813,224) | $ | 1,142,269 | |||||||||||||||||||||||||||
Restricted shares issued under stock-based compensation plans | — | — | (8,082) | 1 | — | 8,221 | 140 | ||||||||||||||||||||||||||||||||||
Impact of tax withholding on stock-based compensation and other | — | — | — | — | — | (4,763) | (4,763) | ||||||||||||||||||||||||||||||||||
Stock-based compensation expense | — | — | 14,001 | — | — | — | 14,001 | ||||||||||||||||||||||||||||||||||
Purchases of treasury shares | — | — | — | — | — | (17,500) | (17,500) | ||||||||||||||||||||||||||||||||||
Class A common stock dividends ($0.3475 per share) | — | — | — | (32,582) | — | — | (32,582) | ||||||||||||||||||||||||||||||||||
Class B common stock dividends ($0.3475 per share) | — | — | — | (6,276) | — | — | (6,276) | ||||||||||||||||||||||||||||||||||
Common stock class conversions | 2 | (2) | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Comprehensive loss, net of tax | — | — | — | 20,358 | (37,840) | — | (17,482) | ||||||||||||||||||||||||||||||||||
Balance at October 31, 2022 | $ | 70,228 | $ | 12,954 | $ | 465,216 | $ | 1,902,661 | $ | (545,986) | $ | (827,266) | $ | 1,077,807 |
University Services | Cross Knowledge | Wiley Edge | Total | ||||||||||||||||||||
Assets held-for-sale: | |||||||||||||||||||||||
Current assets | |||||||||||||||||||||||
Cash and cash equivalents (1) | $ | 216 | $ | 6,348 | $ | 9,733 | $ | 16,297 | |||||||||||||||
Accounts receivable, net | 69,308 | 4,389 | 19,239 | 92,936 | |||||||||||||||||||
Prepaid expenses and other current assets (1) | 2,117 | 3,368 | 5,771 | 11,256 | |||||||||||||||||||
Valuation allowance | — | (14,105) | — | (14,105) | |||||||||||||||||||
Total current assets held-for-sale | $ | 71,641 | $ | — | $ | 34,743 | $ | 106,384 | |||||||||||||||
Technology, property and equipment, net | 14,118 | 2,828 | 2,617 | 19,563 | |||||||||||||||||||
Intangible assets, net | 133,413 | 17,620 | 34,416 | 185,449 | |||||||||||||||||||
Goodwill | — | — | 81,162 | 81,162 | |||||||||||||||||||
Operating lease right-of-use assets | 2,989 | 314 | 970 | 4,273 | |||||||||||||||||||
Other non-current assets | 8,805 | 15,697 | 76 | 24,578 | |||||||||||||||||||
Valuation allowance | (75,466) | (36,459) | — | (111,925) | |||||||||||||||||||
Total non-current assets held-for-sale | $ | 83,859 | $ | — | $ | 119,241 | $ | 203,100 | |||||||||||||||
Liabilities held-for-sale: | |||||||||||||||||||||||
Current liabilities | |||||||||||||||||||||||
Accounts payable | $ | 1,595 | $ | 389 | $ | 2,864 | $ | 4,848 | |||||||||||||||
Accrued royalties | — | 567 | — | 567 | |||||||||||||||||||
Contract liabilities | 828 | 10,893 | — | 11,721 | |||||||||||||||||||
Accrued employment costs | 1,203 | 5,599 | 3,444 | 10,246 | |||||||||||||||||||
Short-term portion of operating lease liabilities | 1,066 | 115 | 453 | 1,634 | |||||||||||||||||||
Other accrued liabilities | 6,312 | 2,796 | 4,153 | 13,261 | |||||||||||||||||||
Total current liabilities held-for-sale | $ | 11,004 | $ | 20,359 | $ | 10,914 | $ | 42,277 | |||||||||||||||
Accrued pension liability | — | 663 | — | 663 | |||||||||||||||||||
Deferred income tax liabilities | — | 4,089 | 3,593 | 7,682 | |||||||||||||||||||
Operating lease liabilities | 3,567 | — | 369 | 3,936 | |||||||||||||||||||
Other long-term liabilities | 383 | 563 | 398 | 1,344 | |||||||||||||||||||
Total long-term liabilities held-for-sale | $ | 3,950 | $ | 5,315 | $ | 4,360 | $ | 13,625 |
(1) | The following table shows a reconciliation of our cash, cash equivalents, and restricted cash included in current assets held-for-sale in our Unaudited Condensed Consolidated Statement of Financial Position to our Unaudited Condensed Consolidated Statement of Cash Flows for the six months ended October 31, 2023: |
Cash and cash equivalents | $ | 83,218 | |||
Restricted cash included in Prepaid expenses and other current assets | 50 | ||||
Total cash, cash equivalents, and restricted cash per Unaudited Condensed Consolidated Statement of Financial Position as of October 31, 2023 | 83,268 | ||||
Cash and cash equivalents held-for-sale | 16,297 | ||||
Restricted cash held-for-sale included in Prepaid expenses and other current assets | 53 | ||||
Total cash, cash equivalents, and restricted cash held-for-sale as of October 31, 2023 | 16,350 | ||||
Total cash, cash equivalents, and restricted cash per Unaudited Condensed Consolidated Statement of Cash Flows for the six months ended October 31, 2023 | $ | 99,618 |
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Research: | |||||||||||||||||||||||
Research Publishing | $ | 219,743 | $ | 232,641 | $ | 442,743 | $ | 472,164 | |||||||||||||||
Research Solutions | 37,927 | 38,718 | 72,731 | 74,108 | |||||||||||||||||||
Total Research | 257,670 | 271,359 | 515,474 | 546,272 | |||||||||||||||||||
Learning: | |||||||||||||||||||||||
Academic | 89,125 | 82,256 | 137,417 | 141,004 | |||||||||||||||||||
Professional | 59,815 | 57,393 | 120,843 | 118,292 | |||||||||||||||||||
Total Learning | 148,940 | 139,649 | 258,260 | 259,296 | |||||||||||||||||||
Held for Sale or Sold | 86,198 | 103,828 | 170,087 | 196,837 | |||||||||||||||||||
Total Revenue | $ | 492,808 | $ | 514,836 | $ | 943,821 | $ | 1,002,405 |
October 31, 2023 | April 30, 2023 | Increase/ (Decrease) | |||||||||||||||
Balances from contracts with customers: | |||||||||||||||||
Accounts receivable, net | $ | 147,253 | $ | 310,121 | $ | (162,868) | |||||||||||
Contract liabilities (1) | 235,839 | 504,695 | (268,856) | ||||||||||||||
Contract liabilities (included in Other long-term liabilities) | $ | 19,563 | $ | 17,426 | $ | 2,137 |
(1) | The sales return reserve recorded in Contract liabilities is $26.2 million and $24.6 million, as of October 31, 2023 and April 30, 2023, respectively. |
October 31, 2023 | April 30, 2023 | ||||||||||
Operating lease ROU assets | $ | 79,009 | $ | 91,197 | |||||||
Short-term portion of operating lease liabilities | 17,804 | 19,673 | |||||||||
Operating lease liabilities, non-current | $ | 101,816 | $ | 115,540 |
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Operating lease cost | $ | 3,855 | $ | 4,528 | $ | 7,938 | $ | 9,710 | |||||||||||||||
Variable lease cost | 297 | 264 | 582 | 542 | |||||||||||||||||||
Short-term lease cost | 292 | 146 | 570 | 261 | |||||||||||||||||||
Sublease income | (218) | (172) | (421) | (370) | |||||||||||||||||||
Total net lease cost (1) | $ | 4,226 | $ | 4,766 | $ | 8,669 | $ | 10,143 |
(1) | Total net lease cost does not include those costs and sublease income included in Restructuring and related charges on our Unaudited Condensed Consolidated Statements of Net (Loss) Income. This includes those operating leases we had identified as part of our restructuring program that would be subleased. See Note 9, “Restructuring and Related Charges” for more information on this program. |
Fiscal Year | Operating Lease Liabilities | |||||||
2024 (remaining 6 months) | $ | 12,312 | ||||||
2025 | 23,291 | |||||||
2026 | 21,481 | |||||||
2027 | 16,954 | |||||||
2028 | 13,246 | |||||||
Thereafter | 64,185 | |||||||
Total future undiscounted minimum lease payments | 151,469 | |||||||
Less: Imputed interest | 31,849 | |||||||
Present value of minimum lease payments | 119,620 | |||||||
Less: Current portion | 17,804 | |||||||
Noncurrent portion | $ | 101,816 |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Restricted Stock: | |||||||||||
Awards granted (shares) | 825 | 539 | |||||||||
Weighted average fair value of grant | $ | 31.66 | $ | 45.35 |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Weighted average fair value of options on grant date | $ | 7.94 | $ | 9.42 | |||||||
Weighted average assumptions: | |||||||||||
Expected life of options (years) | 6.3 | 5.9 | |||||||||
Risk-free interest rate | 3.9 | % | 0.5 | % | |||||||
Expected volatility | 33.5 | % | 31.2 | % | |||||||
Expected dividend yield | 4.3 | % | 3.0 | % | |||||||
Fair value of common stock on grant date | $ | 32.68 | $ | 45.99 | |||||||
Exercise price of stock option grant | $ | 32.68 | $ | 45.99 |
Foreign Currency Translation | Unamortized Retirement Costs | Interest Rate Swaps | Total | ||||||||||||||||||||
Balance at July 31, 2023 | $ | (315,172) | $ | (208,643) | $ | 6,770 | $ | (517,045) | |||||||||||||||
Other comprehensive (loss) income before reclassifications | (33,865) | 8,528 | 1,337 | (24,000) | |||||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 1,466 | (2,391) | (925) | |||||||||||||||||||
Total other comprehensive (loss) income | (33,865) | 9,994 | (1,054) | (24,925) | |||||||||||||||||||
Balance at October 31, 2023 | $ | (349,037) | $ | (198,649) | $ | 5,716 | $ | (541,970) |
Balance at April 30, 2023 | $ | (326,346) | $ | (206,806) | $ | 4,250 | $ | (528,902) | |||||||||||||||
Other comprehensive income (loss) before reclassifications | (22,691) | 5,204 | 6,034 | (11,453) | |||||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 2,953 | (4,568) | (1,615) | |||||||||||||||||||
Total other comprehensive income (loss) | (22,691) | 8,157 | 1,466 | (13,068) | |||||||||||||||||||
Balance at October 31, 2023 | $ | (349,037) | $ | (198,649) | $ | 5,716 | $ | (541,970) |
Foreign Currency Translation | Unamortized Retirement Costs | Interest Rate Swaps | Total | ||||||||||||||||||||
Balance at July 31, 2022 | $ | (349,346) | $ | (177,145) | $ | 3,202 | $ | (523,289) | |||||||||||||||
Other comprehensive (loss) income before reclassifications | (36,148) | 7,089 | 5,804 | (23,255) | |||||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 1,057 | (499) | 558 | |||||||||||||||||||
Total other comprehensive (loss) income | (36,148) | 8,146 | 5,305 | (22,697) | |||||||||||||||||||
Balance at October 31, 2022 | $ | (385,494) | $ | (168,999) | $ | 8,507 | $ | (545,986) |
Balance at April 30, 2022 | $ | (329,566) | $ | (182,226) | $ | 3,646 | $ | (508,146) | |||||||||||||||
Other comprehensive income (loss) before reclassifications | (55,928) | 11,068 | 5,067 | (39,793) | |||||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | — | 2,159 | (206) | 1,953 | |||||||||||||||||||
Total other comprehensive income (loss) | (55,928) | 13,227 | 4,861 | (37,840) | |||||||||||||||||||
Balance at October 31, 2022 | $ | (385,494) | $ | (168,999) | $ | 8,507 | $ | (545,986) |
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Weighted average shares outstanding | 55,102 | 55,622 | 55,186 | 55,679 | |||||||||||||||||||
Shares used for basic earnings per share | 55,102 | 55,622 | 55,186 | 55,679 | |||||||||||||||||||
Dilutive effect of unvested restricted stock units and other stock awards | — | 573 | — | 647 | |||||||||||||||||||
Shares used for diluted earnings per share | 55,102 | 56,195 | 55,186 | 56,326 | |||||||||||||||||||
Antidilutive options to purchase Class A common shares, restricted shares, and contingently issuable restricted stock which are excluded from the table above | 773 | 523 | 819 | 491 |
Three Months Ended October 31, | Six Months Ended October 31, | Total Charges Incurred to Date | |||||||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||||||||
Charges by Segment: | |||||||||||||||||||||||||||||
Research | $ | 4,755 | $ | 1,179 | $ | 6,702 | $ | 1,260 | $ | 9,115 | |||||||||||||||||||
Learning | 5,859 | 3,661 | 6,077 | 6,792 | 13,881 | ||||||||||||||||||||||||
Held for Sale or Sold | 2,022 | 168 | 4,645 | 3,781 | 10,431 | ||||||||||||||||||||||||
Corporate Expenses | 12,119 | 8,673 | 19,111 | 23,589 | 51,990 | ||||||||||||||||||||||||
Total Restructuring and Related Charges | $ | 24,755 | $ | 13,681 | $ | 36,535 | $ | 35,422 | $ | 85,417 | |||||||||||||||||||
Charges by Activity: | |||||||||||||||||||||||||||||
Severance and termination benefits | $ | 18,619 | $ | 5,467 | $ | 24,563 | $ | 17,564 | $ | 50,390 | |||||||||||||||||||
Impairment of operating lease ROU assets and property and equipment | — | 6,590 | 1,575 | 12,696 | 14,271 | ||||||||||||||||||||||||
Acceleration of expense related to operating lease ROU assets and property and equipment | 152 | — | 516 | 1,840 | 2,656 | ||||||||||||||||||||||||
Facility related charges, net | 558 | 999 | 1,387 | 2,697 | 5,537 | ||||||||||||||||||||||||
Consulting costs | 3,966 | 430 | 5,789 | 430 | 8,074 | ||||||||||||||||||||||||
Other activities | 1,460 | 195 | 2,705 | 195 | 4,489 | ||||||||||||||||||||||||
Total Restructuring and Related Charges | $ | 24,755 | $ | 13,681 | $ | 36,535 | $ | 35,422 | $ | 85,417 |
April 30, 2023 | Charges | Payments | Foreign Translation & Other Adjustments | October 31, 2023 | |||||||||||||||||||||||||
Severance and termination benefits | $ | 4,572 | $ | 24,563 | $ | (8,860) | $ | (256) | $ | 20,019 | |||||||||||||||||||
Consulting costs | — | 5,789 | (5,731) | (2) | 56 | ||||||||||||||||||||||||
Other activities | 9 | 2,705 | (778) | (4) | 1,932 | ||||||||||||||||||||||||
Total | $ | 4,581 | $ | 33,057 | $ | (15,369) | $ | (262) | $ | 22,007 |
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Research | $ | 257,670 | $ | 271,359 | $ | 515,474 | $ | 546,272 | |||||||||||||||
Learning | 148,940 | 139,649 | 258,260 | 259,296 | |||||||||||||||||||
Held for Sale or Sold | 86,198 | 103,828 | 170,087 | 196,837 | |||||||||||||||||||
Total revenue | $ | 492,808 | $ | 514,836 | $ | 943,821 | $ | 1,002,405 | |||||||||||||||
Adjusted Contribution to Profit: | |||||||||||||||||||||||
Research | $ | 58,856 | $ | 74,458 | $ | 112,383 | $ | 143,562 | |||||||||||||||
Learning | 39,912 | 33,576 | 47,538 | 37,317 | |||||||||||||||||||
Held for Sale or Sold | 19,100 | 6,862 | 22,184 | (7,246) | |||||||||||||||||||
Total adjusted contribution to profit | 117,868 | 114,896 | 182,105 | 173,633 | |||||||||||||||||||
Adjusted corporate contribution to profit | (46,521) | (43,501) | (88,295) | (92,168) | |||||||||||||||||||
Less: Held for Sale or Sold Segment Adjusted Contribution to Profit (1) | (19,100) | (6,862) | (22,184) | 7,246 | |||||||||||||||||||
Total adjusted operating income | $ | 52,247 | $ | 64,533 | $ | 71,626 | $ | 88,711 | |||||||||||||||
Depreciation and Amortization: | |||||||||||||||||||||||
Research | $ | 22,668 | $ | 23,384 | $ | 45,880 | $ | 47,185 | |||||||||||||||
Learning | 13,974 | 13,900 | 27,526 | 27,955 | |||||||||||||||||||
Held for Sale or Sold (2) | — | 11,227 | 3,437 | 27,494 | |||||||||||||||||||
Total depreciation and amortization | 36,642 | 48,511 | 76,843 | 102,634 | |||||||||||||||||||
Corporate depreciation and amortization | 3,532 | 3,910 | 7,059 | 8,066 | |||||||||||||||||||
Total depreciation and amortization | $ | 40,174 | $ | 52,421 | $ | 83,902 | $ | 110,700 |
(1) | Our Adjusted Operating Income excludes the impact of our Held for Sale or Sold Segment Adjusted Operating Income results. | ||||
(2) | We ceased to record depreciation and amortization of long-lived assets for these businesses as of the date the assets were classified as held-for-sale. On January 1, 2020, Wiley acquired mthree, a talent placement provider that addresses the IT skills gap by finding, training, and placing job-ready technology talent in roles with leading corporations worldwide. Its results of operations are included in our Held for Sale or Sold segment. In late May 2022, Wiley renamed the mthree talent development solution to Wiley Edge and discontinued use of the mthree trademark during the three months ended July 31, 2022. As a result of these actions, we determined that a revision of the useful life was warranted and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022. This amortization expense was an adjustment to the Held for Sale or Sold Adjusted contribution to profit. In addition, it was included in Depreciation and amortization in the table above for segment reporting. |
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
US GAAP Operating Income | $ | 46,245 | $ | 57,439 | $ | 29,890 | $ | 40,474 | |||||||||||||||
Adjustments: | |||||||||||||||||||||||
Restructuring and related charges (1) | 25,102 | 13,956 | 37,225 | 36,397 | |||||||||||||||||||
Impairment of goodwill (1) | — | — | 26,695 | — | |||||||||||||||||||
Accelerated amortization of an intangible asset (2) | — | — | — | 4,594 | |||||||||||||||||||
Held for Sale or Sold segment Adjusted Contribution to Profit (3) | (19,100) | (6,862) | (22,184) | 7,246 | |||||||||||||||||||
Non-GAAP Adjusted Operating Income | $ | 52,247 | $ | 64,533 | $ | 71,626 | $ | 88,711 |
(1) | See Note 9, “Restructuring and Related Charges” and Note 12, “Goodwill and Intangible Assets” for these charges by segment. | ||||
(2) | As described above, this accelerated amortization relates to the mthree trademark. | ||||
(3) | Our Adjusted Operating Income excludes the impact of our Held for Sale or Sold segment Adjusted Operating Income or Loss results. |
October 31, 2023 | April 30, 2023 | ||||||||||
Finished goods | $ | 27,934 | $ | 29,339 | |||||||
Work-in-process | 1,173 | 1,031 | |||||||||
Paper and other materials | 229 | 248 | |||||||||
Total inventories before estimated sales returns and LIFO reserve | $ | 29,336 | $ | 30,618 | |||||||
Inventory value of estimated sales returns | 7,603 | 6,923 | |||||||||
LIFO reserve | (6,808) | (6,808) | |||||||||
Inventories, net | $ | 30,131 | $ | 30,733 |
April 30, 2023 (1)(2) | Impairment | Foreign Translation Adjustment | October 31, 2023 | ||||||||||||||||||||
Research | $ | 609,729 | $ | — | $ | (15,123) | $ | 594,606 | |||||||||||||||
Learning | 486,025 | — | 886 | 486,911 | |||||||||||||||||||
Total excluding Held for Sale or Sold segment | 1,095,754 | — | (14,237) | 1,081,517 | |||||||||||||||||||
Held for Sale or Sold | 108,296 | (26,695) | (439) | 81,162 | |||||||||||||||||||
Total including Held for Sale or Sold segment | $ | 1,204,050 | $ | (26,695) | $ | (14,676) | $ | 1,162,679 |
(1) | The Held for Sale or Sold goodwill balance as of April 30, 2023 includes a cumulative pretax noncash goodwill impairment of $209.8 million. | ||||
(2) | In the three months ended July 31, 2023, we reorganized our segments and due to this realignment have reallocated goodwill. |
October 31, 2023 | April 30, 2023 ⁽¹⁾ | ||||||||||
Intangible assets with definite lives, net: | |||||||||||
Content and publishing rights | $ | 439,157 | $ | 462,463 | |||||||
Customer relationships | 43,708 | 217,346 | |||||||||
Developed technology | 22,751 | 45,500 | |||||||||
Brands and trademarks | 6,188 | 7,281 | |||||||||
Covenants not to compete | 48 | 300 | |||||||||
Total intangible assets with definite lives, net | 511,852 | 732,890 | |||||||||
Intangible assets with indefinite lives: | |||||||||||
Brands and trademarks | 37,000 | 37,000 | |||||||||
Publishing rights | 81,710 | 84,904 | |||||||||
Total intangible assets with indefinite lives | 118,710 | 121,904 | |||||||||
Total intangible assets, net | $ | 630,562 | $ | 854,794 |
(1) | The developed technology balance as of April 30, 2023 is presented net of accumulated impairments and write-offs of $2.8 million. The indefinite-lived brands and trademarks balance as of April 30, 2023 is net of accumulated impairments of $93.1 million. |
Three Months Ended October 31, | Six Months Ended October 31, | ||||||||||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||||||||||
Service cost | $ | 132 | $ | 192 | $ | 266 | $ | 392 | |||||||||||||||
Interest cost | 6,872 | 5,994 | 13,819 | 12,183 | |||||||||||||||||||
Expected return on plan assets | (7,398) | (8,038) | (14,889) | (16,422) | |||||||||||||||||||
Amortization of prior service cost | (24) | (24) | (47) | (47) | |||||||||||||||||||
Amortization of net actuarial loss | 2,000 | 1,467 | 4,026 | 2,991 | |||||||||||||||||||
Net pension expense (income) | $ | 1,582 | $ | (409) | $ | 3,175 | $ | (903) |
October 31, 2023 | April 30, 2023 | ||||||||||
Short-term portion of long-term debt (1) | $ | 5,000 | $ | 5,000 | |||||||
Term loan A - Amended and Restated CA (2) | 189,337 | 191,757 | |||||||||
Revolving credit facility - Amended and Restated CA | 748,287 | 551,535 | |||||||||
Total long-term debt, less current portion | 937,624 | 743,292 | |||||||||
Total debt | $ | 942,624 | $ | 748,292 |
(1) | Relates to our term loan A under the Amended and Restated CA. | ||||
(2) | Amounts are shown net of unamortized issuance costs of $0.7 million as of October 31, 2023 and $0.7 million as of April 30, 2023. |
Notional Amount | ||||||||||||||||||||
Hedged Item (1) | Date entered into | Nature of Swap | October 31, 2023 | April 30, 2023 | Fixed Interest Rate | Variable Interest Rate | ||||||||||||||
Amended and Restated CA | March 15, 2023 | Pay fixed/receive variable | $ | 50,000 | $ | 50,000 | 3.565 | % | 1-month SOFR reset every month for a 3-year period ending April 15, 2026 | |||||||||||
Amended and Restated CA | March 14, 2023 | Pay fixed/receive variable | 50,000 | 50,000 | 4.053 | % | 1-month SOFR reset every month for a 3-year period ending March 15, 2026 | |||||||||||||
Amended and Restated CA | March 13, 2023 | Pay fixed/receive variable | 50,000 | 50,000 | 3.720 | % | 1-month SOFR reset every month for a 3-year period ending March 15, 2026 | |||||||||||||
Amended and Restated CA | December 13, 2022 | Pay fixed/receive variable | 50,000 | 50,000 | 3.772 | % | 1-month SOFR reset every month for a 3-year period ending December 15, 2025 | |||||||||||||
Amended and Restated CA | June 16, 2022 | Pay fixed/receive variable | 100,000 | 100,000 | 3.467 | % | 1-month SOFR reset every month for a 2-year period ending May 15, 2024 | |||||||||||||
Amended and Restated CA | April 6, 2022 | Pay fixed/receive variable | 100,000 | 100,000 | 2.588 | % | 1-month SOFR reset every month for a 2-year period ending April 15, 2024 | |||||||||||||
Amended and Restated CA | April 12, 2021 | Pay fixed/receive variable | 100,000 | 100,000 | 0.465 | % | 1-month SOFR reset every month for a 3-year period ending April 15, 2024 | |||||||||||||
$ | 500,000 | $ | 500,000 |
(1) | On November 30, 2022, we entered into the Second Amendment to our Amended and Restated CA. Refer to Note 15, "Debt and Available Credit Facilities" for more information related to our Amended and Restated CA. |
Date of Declaration by Board of Directors | Quarterly Cash Dividend | Total Dividend | Class of Common Stock | Dividend Paid Date | Shareholders of Record as of Date | |||||||||||||||||||||||||||
June 26, 2023 | $0.3500 per common share | $19.4 million | Class A and Class B | July 20, 2023 | July 6, 2023 | |||||||||||||||||||||||||||
September 28, 2023 | $0.3500 per common share | $19.3 million | Class A and Class B | October 25, 2023 | October 10, 2023 |
Changes in Common Stock A: | 2023 | 2022 | |||||||||
Number of shares issued, beginning of year | 70,231 | 70,226 | |||||||||
Common stock class conversions | 3 | 2 | |||||||||
Number of shares issued, end of period | 70,234 | 70,228 | |||||||||
Changes in Common Stock A in treasury: | |||||||||||
Number of shares held, beginning of year | 23,983 | 23,515 | |||||||||
Purchases of treasury shares | 668 | 382 | |||||||||
Restricted shares issued under stock-based compensation plans – non-PSU Awards | (151) | (125) | |||||||||
Restricted shares issued under stock-based compensation plans – PSU Awards | (233) | (150) | |||||||||
Shares issued to directors | (7) | (3) | |||||||||
Shares withheld for taxes | 133 | 100 | |||||||||
Number of shares held, end of period | 24,393 | 23,719 | |||||||||
Number of Common Stock A outstanding, end of period | 45,841 | 46,509 |
Changes in Common Stock B: | 2023 | 2022 | |||||||||
Number of shares issued, beginning of year | 12,951 | 12,956 | |||||||||
Common stock class conversions | (3) | (2) | |||||||||
Number of shares issued, end of period | 12,948 | 12,954 | |||||||||
Changes in Common Stock B in treasury: | |||||||||||
Number of shares held, beginning of year | 3,925 | 3,924 | |||||||||
Purchases of treasury shares | 1 | — | |||||||||
Number of shares held, end of period | 3,926 | 3,924 | |||||||||
Number of Common Stock B outstanding, end of period | 9,022 | 9,030 |
Three Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP Revenue, net | $ | 492,808 | $ | 514,836 | |||||||
Less: Held for Sale or Sold segment (1) | (86,198) | (103,828) | |||||||||
Non-GAAP Adjusted Revenue, net | $ | 406,610 | $ | 411,008 |
(1) | Our Adjusted Revenue, net excludes the impact of our Held for Sale or Sold segment revenue. |
Three Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP Operating Income | $ | 46,245 | $ | 57,439 | |||||||
Adjustments: | |||||||||||
Restructuring and related charges | 25,102 | 13,956 | |||||||||
Held for Sale or Sold segment adjusted contribution to profit (1) | (19,100) | (6,862) | |||||||||
Non-GAAP Adjusted OI | $ | 52,247 | $ | 64,533 |
(1) | Our Adjusted OI excludes the impact of our Held for Sale or Sold segment adjusted contribution to profit. |
Three Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Net (Loss) Income | $ | (19,445) | $ | 38,193 | |||||||
Interest expense | 12,937 | 9,332 | |||||||||
(Benefit) provision for income taxes | (2,585) | 10,137 | |||||||||
Depreciation and amortization | 40,174 | 52,421 | |||||||||
Non-GAAP EBITDA | 31,081 | 110,083 | |||||||||
Restructuring and related charges | 25,102 | 13,956 | |||||||||
Foreign exchange losses (gains), including the write off of certain cumulative translation adjustments | 2,357 | (478) | |||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | 51,414 | — | |||||||||
Other expense, net | 1,567 | 255 | |||||||||
Held for Sale or Sold segment Adjusted EBITDA (1) | (19,100) | (18,089) | |||||||||
Non-GAAP Adjusted EBITDA | $ | 92,421 | $ | 105,727 |
(1) | Our Non-GAAP Adjusted EBITDA excludes the Held for Sale or Sold segment Non-GAAP Adjusted EBITDA. |
Three Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP (Loss) Income Before Taxes | $ | (22,030) | $ | 48,330 | |||||||
Pretax Impact of Adjustments: | |||||||||||
Restructuring and related charges | 25,102 | 13,956 | |||||||||
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 3,223 | 2,654 | |||||||||
Amortization of acquired intangible assets | 14,303 | 21,185 | |||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | 51,414 | — | |||||||||
Held for Sale or Sold segment Adjusted Income Before Taxes (1) | (19,099) | (13,230) | |||||||||
Non-GAAP Adjusted Income Before Taxes | $ | 52,913 | $ | 72,895 |
(1) | Our Adjusted Income Before Taxes excludes the Adjusted Income of our Held for Sale or Sold segment. |
(1) | For the three months ended October 31, 2023 and 2022, substantially all of the tax impact was from deferred taxes. | ||||
(2) | Our Adjusted Income Tax Provision excludes the Adjusted Tax Provision of our Held for Sale or Sold segment. |
Three Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP (Loss) Earnings Per Share | $ | (0.35) | $ | 0.68 | |||||||
Adjustments: | |||||||||||
Restructuring and related charges | 0.34 | 0.19 | |||||||||
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 0.04 | 0.03 | |||||||||
Amortization of acquired intangible assets | 0.19 | 0.30 | |||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | 0.77 | — | |||||||||
Held for Sale or Sold segment Adjusted Net Income (1) | (0.27) | (0.18) | |||||||||
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (2) | 0.01 | — | |||||||||
Non-GAAP Adjusted EPS | $ | 0.73 | $ | 1.02 |
(1) | Our Adjusted EPS excludes the Adjusted Net Income of our Held for Sale or Sold segment. | ||||
(2) | Represents the impact of using diluted weighted-average number of common shares outstanding (55.6 million shares for the three months ended October 31, 2023) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive. |
RESEARCH | Three Months Ended October 31, | % Change Favorable (Unfavorable) | Constant Currency % Change Favorable (Unfavorable) | ||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Research Publishing | $ | 219,743 | $ | 232,641 | (6) | % | (7) | % | |||||||||||||||
Research Solutions | 37,927 | 38,718 | (2) | % | (3) | % | |||||||||||||||||
Total Research Revenue | 257,670 | 271,359 | (5) | % | (7) | % | |||||||||||||||||
Cost of Sales | 71,300 | 71,033 | 0 | % | 1 | % | |||||||||||||||||
Operating Expenses | 116,228 | 114,252 | (2) | % | 1 | % | |||||||||||||||||
Amortization of Intangible Assets | 11,286 | 11,616 | 3 | % | 5 | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 4,755 | 1,179 | # | # | |||||||||||||||||||
Contribution to Profit | 54,101 | 73,279 | (26) | % | (26) | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 4,755 | 1,179 | # | # | |||||||||||||||||||
Adjusted Contribution to Profit | 58,856 | 74,458 | (21) | % | (21) | % | |||||||||||||||||
Depreciation and amortization | 22,668 | 23,384 | 3 | % | 4 | % | |||||||||||||||||
Adjusted EBITDA | $ | 81,524 | $ | 97,842 | (17) | % | (17) | % | |||||||||||||||
Adjusted EBITDA Margin | 31.6% | 36.1% |
Three Months Ended October 31, | % Change Favorable (Unfavorable) | Constant Currency % Change Favorable (Unfavorable) | |||||||||||||||||||||
LEARNING: | 2023 | 2022 | |||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Academic | $ | 89,125 | $ | 82,256 | 8 | % | 8 | % | |||||||||||||||
Professional | 59,815 | 57,393 | 4 | % | 3 | % | |||||||||||||||||
Total Learning Revenue | 148,940 | 139,649 | 7 | % | 6 | % | |||||||||||||||||
Cost of Sales | 35,617 | 34,768 | (2) | % | (1) | % | |||||||||||||||||
Operating Expenses | 71,132 | 69,180 | (3) | % | (2) | % | |||||||||||||||||
Amortization of Intangible Assets | 2,279 | 2,125 | (7) | % | (7) | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 5,859 | 3,664 | (60) | % | (60) | % | |||||||||||||||||
Contribution to Profit | 34,053 | 29,912 | 14 | % | 14 | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 5,859 | 3,664 | (60) | % | (60) | % | |||||||||||||||||
Adjusted Contribution to Profit | 39,912 | 33,576 | 19 | % | 19 | % | |||||||||||||||||
Depreciation and amortization | 13,974 | 13,900 | (1) | % | 0 | % | |||||||||||||||||
Adjusted EBITDA | $ | 53,886 | $ | 47,476 | 14 | % | 13 | % | |||||||||||||||
Adjusted EBITDA Margin | 36.2% | 34.0% |
Three Months Ended October 31, | % Change Favorable (Unfavorable) | Constant Currency % Change Favorable (Unfavorable) | |||||||||||||||||||||
HELD FOR SALE OR SOLD: | 2023 | 2022 | |||||||||||||||||||||
Total Held for Sale or Sold Revenue | $ | 86,198 | $ | 103,828 | (17) | % | (18) | % | |||||||||||||||
Cost of Sales | 48,697 | 64,501 | 25 | % | 26 | % | |||||||||||||||||
Operating Expenses | 18,401 | 26,096 | 29 | % | 32 | % | |||||||||||||||||
Amortization of Intangible Assets | — | 6,369 | # | # | |||||||||||||||||||
Restructuring Charges (see Note 9) | 2,022 | 281 | # | # | |||||||||||||||||||
Contribution to Profit | 17,078 | 6,581 | # | # | |||||||||||||||||||
Restructuring Charges (see Note 9) | 2,022 | 281 | # | # | |||||||||||||||||||
Adjusted Contribution to Profit | 19,100 | 6,862 | # | # | |||||||||||||||||||
Depreciation and amortization | — | 11,227 | # | # | |||||||||||||||||||
Adjusted EBITDA | $ | 19,100 | $ | 18,089 | 6 | % | 4 | % | |||||||||||||||
Adjusted EBITDA Margin | 22.2% | 17.4% |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP Revenue, net | $ | 943,821 | $ | 1,002,405 | |||||||
Less: Held for Sale or Sold segment (1) | (170,087) | (196,837) | |||||||||
Non-GAAP Adjusted Revenue, net | $ | 773,734 | $ | 805,568 |
(1) | Our Adjusted Revenue, net excludes the impact of our Held for Sale or Sold segment revenue. |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP Operating Income | $ | 29,890 | $ | 40,474 | |||||||
Adjustments: | |||||||||||
Restructuring and related charges | 37,225 | 36,397 | |||||||||
Impairment of goodwill | 26,695 | — | |||||||||
Accelerated amortization of an intangible asset (1) | — | 4,594 | |||||||||
Held for Sale or Sold segment adjusted contribution to profit (2) | (22,184) | 7,246 | |||||||||
Non-GAAP Adjusted OI | $ | 71,626 | $ | 88,711 |
(1) | We determined that a revision of the useful life of the mthree trademark was warranted and the intangible asset was fully amortized over its remaining useful life resulting in accelerated amortization expense of $4.6 million in the three months ended July 31, 2022. | ||||
(2) | Our Adjusted OI excludes the impact of our Held for Sale or Sold segment adjusted contribution to profit. |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Net (Loss) Income | $ | (111,709) | $ | 20,358 | |||||||
Interest expense | 24,271 | 15,664 | |||||||||
(Benefit) provision for income taxes | (17,044) | 4,585 | |||||||||
Depreciation and amortization | 83,902 | 110,700 | |||||||||
Non-GAAP EBITDA | (20,580) | 151,307 | |||||||||
Impairment of goodwill | 26,695 | — | |||||||||
Restructuring and related charges | 37,225 | 36,397 | |||||||||
Foreign exchange losses, including the write off of certain cumulative translation adjustments | 3,977 | 138 | |||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | 127,343 | — | |||||||||
Other expense (income), net | 3,052 | (271) | |||||||||
Held for Sale or Sold segment Adjusted EBITDA (1) | (25,621) | (15,654) | |||||||||
Non-GAAP Adjusted EBITDA | $ | 152,091 | $ | 171,917 |
(1) | Our Non-GAAP Adjusted EBITDA excludes the Held for Sale or Sold segment Non-GAAP Adjusted EBITDA. |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP (Loss) Income Before Taxes | $ | (128,753) | $ | 24,943 | |||||||
Pretax Impact of Adjustments: | |||||||||||
Impairment of goodwill | 26,695 | — | |||||||||
Restructuring and related charges | 37,225 | 36,397 | |||||||||
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 3,217 | 3,320 | |||||||||
Amortization of acquired intangible assets | 30,971 | 47,570 | |||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | 127,343 | — | |||||||||
Held for Sale or Sold segment Adjusted Income Before Taxes (1) | (24,133) | (5,636) | |||||||||
Non-GAAP Adjusted Income Before Taxes | $ | 72,565 | $ | 106,594 |
(1) | Our Adjusted Income Before Taxes excludes the Adjusted Income of our Held for Sale or Sold segment. |
(1) | For the six months ended October 31, 2023 and 2022, substantially all of the tax impact was from deferred taxes. | ||||
(2) | Our Adjusted Income Tax Provision excludes the Adjusted Tax Provision of our Held for Sale or Sold segment. |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
US GAAP (Loss) Earnings Per Share | $ | (2.02) | $ | 0.36 | |||||||
Adjustments: | |||||||||||
Impairment of goodwill | 0.43 | — | |||||||||
Restructuring and related charges | 0.50 | 0.49 | |||||||||
Foreign exchange losses on intercompany transactions, including the write off of certain cumulative translation adjustments | 0.04 | 0.04 | |||||||||
Amortization of acquired intangible assets | 0.42 | 0.67 | |||||||||
Impairment charge related to assets held-for-sale and loss on sale of a business | 1.94 | — | |||||||||
Held for Sale or Sold segment Adjusted Net Income (1) | (0.34) | (0.08) | |||||||||
EPS impact of using weighted-average dilutive shares for adjusted EPS calculation (2) | 0.02 | — | |||||||||
Non-GAAP Adjusted EPS | $ | 0.99 | $ | 1.48 |
(1) | Our Adjusted EPS excludes the Adjusted Net Income of our Held for Sale or Sold segment. | ||||
(2) | Represents the impact of using diluted weighted-average number of common shares outstanding (55.7 million shares for the six months ended October 31, 2023) included in the Non-GAAP Adjusted EPS calculation in order to apply the dilutive impact on adjusted net income due to the effect of unvested restricted stock units and other stock awards. This impact occurs when a US GAAP net loss is reported and the effect of using dilutive shares is antidilutive. |
RESEARCH | Six Months Ended October 31, | % Change Favorable (Unfavorable) | Constant Currency % Change Favorable (Unfavorable) | ||||||||||||||||||||
2023 | 2022 | ||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Research Publishing | $ | 442,743 | $ | 472,164 | (6) | % | (7) | % | |||||||||||||||
Research Solutions | 72,731 | 74,108 | (2) | % | (3) | % | |||||||||||||||||
Total Research Revenue | 515,474 | 546,272 | (6) | % | (7) | % | |||||||||||||||||
Cost of Sales | 141,567 | 142,302 | 1 | % | 2 | % | |||||||||||||||||
Operating Expenses | 238,862 | 236,971 | (1) | % | 1 | % | |||||||||||||||||
Amortization of Intangible Assets | 22,662 | 23,437 | 3 | % | 5 | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 6,702 | 1,260 | # | # | |||||||||||||||||||
Contribution to Profit | 105,681 | 142,302 | (26) | % | (26) | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 6,702 | 1,260 | # | # | |||||||||||||||||||
Adjusted Contribution to Profit | 112,383 | 143,562 | (22) | % | (22) | % | |||||||||||||||||
Depreciation and amortization | 45,880 | 47,185 | 3 | % | 4 | % | |||||||||||||||||
Adjusted EBITDA | $ | 158,263 | $ | 190,747 | (17) | % | (18) | % | |||||||||||||||
Adjusted EBITDA Margin | 30.7% | 34.9% |
Six Months Ended October 31, | % Change Favorable (Unfavorable) | Constant Currency % Change Favorable (Unfavorable) | |||||||||||||||||||||
LEARNING: | 2023 | 2022 | |||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Academic | $ | 137,417 | $ | 141,004 | (3) | % | (3) | % | |||||||||||||||
Professional | 120,843 | 118,292 | 2 | % | 2 | % | |||||||||||||||||
Total Learning Revenue | 258,260 | 259,296 | 0 | % | (1) | % | |||||||||||||||||
Cost of Sales | 66,941 | 69,548 | 4 | % | 4 | % | |||||||||||||||||
Operating Expenses | 139,233 | 148,045 | 6 | % | 7 | % | |||||||||||||||||
Amortization of Intangible Assets | 4,548 | 4,386 | (4) | % | (4) | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 6,077 | 6,795 | 11 | % | 11 | % | |||||||||||||||||
Contribution to Profit | 41,461 | 30,522 | 36 | % | 36 | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 6,077 | 6,795 | 11 | % | 11 | % | |||||||||||||||||
Adjusted Contribution to Profit | 47,538 | 37,317 | 27 | % | 28 | % | |||||||||||||||||
Depreciation and amortization | 27,526 | 27,955 | 2 | % | 2 | % | |||||||||||||||||
Adjusted EBITDA | $ | 75,064 | $ | 65,272 | 15 | % | 15 | % | |||||||||||||||
Adjusted EBITDA Margin | 29.1% | 25.2% |
Six Months Ended October 31, | % Change Favorable (Unfavorable) | Constant Currency % Change Favorable (Unfavorable) | |||||||||||||||||||||
HELD FOR SALE OR SOLD: | 2023 | 2022 | |||||||||||||||||||||
Total Held for Sale or Sold Revenue | $ | 170,087 | $ | 196,837 | (14) | % | (15) | % | |||||||||||||||
Cost of Sales | 104,207 | 132,483 | 21 | % | 22 | % | |||||||||||||||||
Operating Expenses | 41,693 | 58,717 | 29 | % | 30 | % | |||||||||||||||||
Impairment of Goodwill (see Note 12) | 26,695 | — | # | # | |||||||||||||||||||
Amortization of Intangible Assets | 2,003 | 17,477 | 89 | % | 88 | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 4,645 | 3,773 | (23) | % | (23) | % | |||||||||||||||||
Contribution to Profit | (9,156) | (15,613) | 41 | % | 39 | % | |||||||||||||||||
Restructuring Charges (see Note 9) | 4,645 | 3,773 | (23) | % | (23) | % | |||||||||||||||||
Impairment of Goodwill (see Note 12) | 26,695 | — | # | # | |||||||||||||||||||
Accelerated Amortization of an Intangible Asset | — | 4,594 | # | # | |||||||||||||||||||
Adjusted Contribution to Profit | 22,184 | (7,246) | # | # | |||||||||||||||||||
Depreciation and amortization | 3,437 | 22,900 | 85 | % | 85 | % | |||||||||||||||||
Adjusted EBITDA | $ | 25,621 | $ | 15,654 | 64 | % | 62 | % | |||||||||||||||
Adjusted EBITDA Margin | 15.1% | 8.0% |
Metric | Fiscal Year 2023 All Company | Fiscal Year 2023 Ex-Divestitures | Fiscal Year 2024 Outlook Ex-Divestitures | ||||||||||||||
Adjusted Revenue (1) | $2,020 | $1,627 | $1,580 to $1,630 | ||||||||||||||
Research | $1,080 | Flat to low-single digit decline (+2% excluding Hindawi) | |||||||||||||||
Learning | $547 | Flat to low-single digit increase | |||||||||||||||
Adjusted EBITDA (1) | $422 | $379 | $305 to $330 | ||||||||||||||
Adjusted EPS (1) | $3.84 | $3.48 | $2.05 to $2.40 |
(1) | Wiley’s fiscal year 2024 outlook (Adjusted Revenue, Adjusted EBITDA, and Adjusted EPS) exclude businesses held-for-sale, including University Services, Wiley Edge (formerly Talent Development), and CrossKnowledge, as well as those sold in fiscal year 2023, Test Prep and Advancement Courses. |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Net cash used in operating activities | $ | (83,486) | $ | (76,196) | |||||||
Net cash used in investing activities | (51,917) | (48,293) | |||||||||
Net cash provided by financing activities | 129,702 | 151,603 | |||||||||
Effect of foreign currency exchange rate changes on cash, cash equivalents and restricted cash | $ | (1,943) | $ | (8,784) |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Net cash used in operating activities | $ | (83,486) | $ | (76,196) | |||||||
Less: Additions to technology, property and equipment | (40,321) | (38,530) | |||||||||
Less: Product development spending | (8,168) | (11,445) | |||||||||
Free cash flow less product development spending | $ | (131,975) | $ | (126,171) |
Net cash used in operating activities – Six months ended October 31, 2022 | $ | (76.2) | |||
Net loss adjusted for items to reconcile net loss to net cash used in operating activities, which would include such noncash items as depreciation and amortization, impairment of goodwill, impairment charge related to assets held-for-sale and loss on sale of a business, restructuring charges, and the change in deferred taxes | (29.6) | ||||
Working capital changes: | |||||
Accounts receivable, net and contract liabilities | 11.9 | ||||
Accounts payable and accrued royalties | (21.0) | ||||
Changes in other assets and liabilities | 31.4 | ||||
Net cash used in operating activities – Six months ended October 31, 2023 | $ | (83.5) |
Six Months Ended October 31, | |||||||||||
2023 | 2022 | ||||||||||
Shares repurchased – Class A | 668 | 382 | |||||||||
Shares repurchased – Class B | 1 | — | |||||||||
Average price – Class A and Class B | $ | 33.64 | $ | 45.84 |
October 31, 2023 | April 30, 2023 | ||||||||||
Increase in Inventories, net | $ | 7,603 | $ | 6,923 | |||||||
Decrease in Accrued royalties | $ | (3,217) | $ | (3,240) | |||||||
Increase in Contract liabilities | $ | 26,220 | $ | 24,582 | |||||||
Print book sales return reserve net liability balance | $ | (15,400) | $ | (14,419) |
Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as part of a Publicly Announced Program | Maximum Number of Shares that May be Purchased Under the Program | Maximum Dollar Value of Shares that May be Purchased Under Additional Plans or Programs (Dollars in millions) | |||||||||||||||||||||||||
August 2023 | — | $ | — | — | — | $ | 152.5 | ||||||||||||||||||||||
September 2023 | 156,956 | 36.95 | 156,956 | — | 146.7 | ||||||||||||||||||||||||
October 2023 | 211,065 | 31.75 | 211,065 | — | 140.0 | ||||||||||||||||||||||||
Total | 368,021 | $ | 33.97 | 368,021 | — | $ | 140.0 |
Material Contracts | |||||
Form of the Fiscal Year 2024 Executive Annual Incentive Plan ● | |||||
Form of the Fiscal Year 2024 Executive Long Term Incentive Plan ● | |||||
Restricted Share Unit Grant Agreement for Matthew Kissner under the Executive Long-Term Incentive Plan, Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan ● | |||||
Non-Qualified Premium Stock Option Grant Agreement, Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan ● | |||||
Performance Share Unit Grant Agreement under the Executive Long-Term Incentive Plan, under the Business Officer Equity Program, Pursuant to the 2022 Omnibus Stock Plan and Long-Term Incentive Plan ● | |||||
Executive Severance Plan (“ESP”), with an effective date of June 20, 2016, as amended September 22, 2023● | |||||
Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |||||
Certification of Interim Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||
Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |||||
Certification of Interim Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||
Inline XBRL | |||||
101.INS* | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). | ||||
101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | ||||
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | ||||
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. | ||||
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. | ||||
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | ||||
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | ||||
JOHN WILEY & SONS, INC. Registrant | ||||||||
By | /s/ Matthew S. Kissner | |||||||
Matthew S. Kissner | ||||||||
Interim President and Chief Executive Officer | ||||||||
By | /s/ Christina Van Tassell | |||||||
Christina Van Tassell | ||||||||
Executive Vice President and Chief Financial Officer | ||||||||
By | /s/ Christopher F. Caridi | |||||||
Christopher F. Caridi | ||||||||
Senior Vice President, Global Corporate Controller and Chief Accounting Officer | ||||||||
Dated: December 7, 2023 |
Section | Subject | Page | ||||||
I. | Definitions | 2 | ||||||
II. | Plan Objectives | 3 | ||||||
III. | Eligibility | 3 | ||||||
IV. | Performance Measurement | 3 | ||||||
V. | Performance Evaluation | 4 | ||||||
VI. | Payouts | 5 | ||||||
VII. | Administration and Other Matters | 5 |
Section | Subject | Page | ||||||
I. | Definitions | 2 | ||||||
II. | Plan Objectives | 3 | ||||||
III. | Eligibility | 3 | ||||||
IV. | Performance Targets and Measurement | 4 | ||||||
V. | Performance Evaluation | 4 | ||||||
VI. | Performance Share Unit Award Provisions | 5 | ||||||
VII. | Restricted Share Units | 5 | ||||||
VIII. | Payouts | 5 | ||||||
IX. | Administration and Other Matters | 7 |
Definition of Cause: (A)Executive’s refusal or willful and continued failure to substantially perform Executive’s material duties to the best of Executive’s ability (for reasons other than death or disability), in any such case after written notice thereof and your failure to remedy such refusal or failure; (B) Executive’s gross negligence in the performance of Executive’s material duties; (C) any act of fraud, misappropriation, material dishonesty, embezzlement, willful misconduct or similar conduct; (D) Executive’s conviction of or plea of guilty or nolo contendere to a felony or any crime involving moral turpitude; (E) Executive’s engagement in conduct that brings or is reasonably likely to bring the Company negative publicity or into public disgrace, embarrassment or disrepute; or (F) Executive’s material and willful violation of any of the Company’s reasonable rules, regulations, policies, directions and restrictions. |
By: | /s/ Matthew S. Kissner | |||||||
Matthew S. Kissner | ||||||||
Interim President and Chief Executive Officer | ||||||||
Dated: December 7, 2023 |
By: | /s/ Christina Van Tassell | |||||||
Christina Van Tassell | ||||||||
Executive Vice President and Chief Financial Officer | ||||||||
Dated: December 7, 2023 |
By: | /s/ Matthew S. Kissner | |||||||
Matthew S. Kissner | ||||||||
Interim President and Chief Executive Officer | ||||||||
Dated: December 7, 2023 |
By: | /s/ Christina Van Tassell | |||||||
Christina Van Tassell | ||||||||
Executive Vice President and Chief Financial Officer | ||||||||
Dated: December 7, 2023 |